… data about outcomes of consecutive metastatic breast cancer patients treated at … breast
cancer in distinct subgroups with the aim of obtaining more precise information about prognosis …

… In the present study the outcomes of patients with truly disseminated disease was
explored. Patients with loco regional recurrence or a new primary in the contra lateral …

… overall survival of breast cancer patients with distant recurrence or de novo metastatic disease
… We found no evidence for an improvement in survival between 1980 and 1990, consistent …

… Survival differences observed in metastatic breast cancer patients treated with … outcome
in metastatic breast cancer treated with adriamycin combination chemotherapy. Cancer …

… In summary, we report that MF and MC breast cancers are associated with a number of
more aggressive features, including an increased rate of regional lymph node metastases. …

… characteristics and survival of de novo metastatic breast cancer according to metastatic
sites using the SEER data. Metastatic breast cancer (MBC) is widely known to have a poor …

… in women in the US In 2005, an estimated 211,240 new cases of invasive breast cancer
are … of breast cancer continues to gradually increase. The mortality rate from breast cancer …

… outcome comparisons and help the development of new therapeutic strategies. To this
end, we aimed to describe the full characteristics and outcomes … metastatic breast cancer (MBC). …

… The favorable survival outcome in breast cancer is mainly due to two factors: (1) detection
of disease at an early stage with screening mammography, which is in common use, and (2) …

… alterations on prognosis is critical. … breast cancer subtypes. Furthermore, we report the effect
of common genotypes on prognosis in hormone receptor–positive (HR+) breast cancer. We …